Approaches for optimal use of different COVID-19 vaccines


What The Article Says:

This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson & Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination and single mRNA immunization of people with prior documented SARS-CoV-2 infection.


Authors:

John P. Moore, Ph.D., of Weill Cornell Medicine in New York, is the corresponding author.


To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jama.2021.3465)


Editor’s Note:

The article includes an Editor’s Note. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###


Media advisory:

The full article is linked to this news release. A livestream with the author also is scheduled for Thursday at 3:50 P.M. (ET) and will be available here:

http://ja.

ma/

moore0304


Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

/

jamanetwork.

com/

journals/

jama/

fullarticle/

10.

1001/

jama.

2021.

3465?guestAccessKey=

a44d6501-b605-47f2-970e-f8cc12936363&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

030421

This part of information is sourced from https://www.eurekalert.org/pub_releases/2021-03/jn-afo030421.php

withyou android app